Cardiovascular Diseases Clinical Trials in Bethesda, Maryland
4 studies are recruiting for cardiovascular diseases in Bethesda, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Background: Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those organs. Current imaging scans can see this scar tissue once it has formed, but researchers want to find a way to detect the fibrosis in its earliest stages, while there might still b…
- Stage
- Phase 3
- Ages
- 18 to 100
- Site
- National Institutes of Health Clinical Center, Bethesda, Maryland
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
-
Diabetes and Heart Disease Risk in Blacks
It is unknown if obesity contributes to the development of heart disease in African American men and women. This study was created to determine whether there is a relationship between sex and body size and the incidence of heart disease in African American men and women. Researchers will attempt to…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- National Institutes of Health Clinical Center, Bethesda, Maryland
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
-
Thrombosis and Inflammation in Vessels Initiative (TIVI)
Background: Diseases related to the immune system, blood clots, and blood vessels can affect every part of the body. These diseases are now known to be interrelated: People who have strokes, blood clots in their legs, or autoimmune disease, for example, are at greater risk of complications in the h…
- Stage
- Not phased
- Ages
- 5 to 100
- Site
- National Institutes of Health Clinical Center, Bethesda, Maryland
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
-
The Oxford Risk Factors And Non-Invasive Imaging Study
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
- Stage
- Not phased
- Ages
- 18 to 99
- Site
- NIH National Heart, Lunch, and Blood Institute, Bethesda, Maryland
- Locations
- 45 in total
- Run by
- University of Oxford
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.